Cushing's syndrome: Treatment and new therapeutic approaches

Best Pract Res Clin Endocrinol Metab. 2020 Mar;34(2):101381. doi: 10.1016/j.beem.2020.101381. Epub 2020 Jan 30.

Abstract

Overt Cushing's syndrome is a severe condition responsible for multiple comorbidities and increased mortality. Effective treatment is essential to reduce mortality, improve comorbidities and long-term quality of life. Surgical resection of the causal lesion(s) is generally the first-line and most effective treatment to normalize cortisol secretion. Adjunctive symptomatic treatments of co-morbidities are often necessary both during the active phase of the disease and for persisting co-morbidities after cessation of hypercortisolism. Second-line treatments include various pharmacological treatments, bilateral adrenalectomy, and radiotherapy of corticotroph tumors. The choice of these treatments is complex, must be performed in a multidisciplinary expert team to be individualized for each patient, and use a shared decision-making approach.

Keywords: Cushing's syndrome; anticortisolic drugs; bilateral adrenalectomy; intense hypercortisolism; pituitary radiotherapy; surgery.

Publication types

  • Review

MeSH terms

  • Adrenalectomy / adverse effects
  • Cushing Syndrome / diagnosis
  • Cushing Syndrome / epidemiology
  • Cushing Syndrome / etiology
  • Cushing Syndrome / therapy*
  • Diagnostic Techniques, Endocrine
  • Humans
  • Quality of Life
  • Therapies, Investigational* / methods
  • Therapies, Investigational* / trends
  • Treatment Outcome